Tuesday, September 28, 2021
wellness India Expo
Home Tags Zydus

Tag: Zydus

Zydus seeks DCGI’s EUA for world’s first Plasmid DNA based COVID-19...

The company has presented interim results from Phase III clinical trials in over 28,000 volunteers in a study carried out in more than 50 clinical sites spread across the country and during the peak of second wave of COVID-19.......................

Bayer & Zydus extend their joint venture by 3 years

Bayer Zydus Pharma will continue to operate in therapies including cardiology, diabetes, women’s health, ophthalmology and oncology, with new products in the pipeline.......................

Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b...

Promising interim results from Phase III clinical trials with Pegylated Interferon alpha-2b in COVID-19 show higher clinical improvement.........................

Zydus completes Phase-I trials of its anti-malarial compound

Phase I healthy volunteers study demonstrated long half-life and potential for a single-dose cure for malaria. Potent antimalarial activity demonstrated in malaria challenge trial following single-dose oral administration of ZY19489.......................

Zydus’ Desidustat shows efficacy & safety in treating Hypoxia in hospitalized...

Novel mechanism of targeting ‘hypoxia’ through HIF-PH inhibitor was studied for the first time in Hospitalised Covid-19 Patients in Mexico. Study trial indicates that the use of Desidustat for 14 days reduced CRP between baseline and day 14 among hospitalised patients with COVID-19.........................

Zydus Cadila vaccine candidate gets nod for Phase III clinical trials

The candidate has been supported by the National Biopharma Mission (NBM) under the aegis of BIRAC and the Department of Biotechnology, Government of India.......................

Zydus to begin Phase I trials of its inflammation drug, ZYIL1

Phase I trial will study the safety, tolerability, pharmacokinetics and pharmacodynamics of ZYIL1 in healthy human volunteers. Zydus has secured a Strong IP portfolio with multiple patents filed in all major countries.....................

Zydus gets DCGI’s approval for phase III clinical trials of its...

According to the company, Pegylated Interferon alpha – 2b significantly increased viral reduction and reduced the need for supplemental oxygen in moderate COVID-19 patients........................

Zydus completes Phase II clinical trials of COVID-19 biological therapy, to...

Pegylated Interferon alpha – 2b significantly increased viral reduction and reduced the need for supplemental oxygen in moderate COVID-19 patients; the Company will now commence Phase III clinical trials..............

DBT supported & Zydus driven COVID 19 vaccine, ZyCoV-D begins phase...

Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the National Biopharma Mission, implemented by BIRAC moves into clinical trials The study will assess the safety, tolerability and immunogenicity of the vaccine.................